학술논문

Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system.
Document Type
Article
Source
Acta Diabetologica. May2022, Vol. 59 Issue 5, p743-746. 4p.
Subject
*TYPE 1 diabetes
*HYBRID systems
*YOUNG adults
*TEENAGERS
*INJECTIONS
*LONGITUDINAL method
Language
ISSN
0940-5429
Abstract
Insulin and AHCL were initiated in auto mode (algorithm glucose target 100-120 mg/dl (5.5-6.7 mmol/l), AIT 2-4 h and automated bolus correction ON) and was used continuously for 12 weeks of the study. Keywords: Type 1 diabetes; Continuous subcutaneous insulin infusion; Continuous glucose monitoring; Diabetes education; Closed-loop systems EN Type 1 diabetes Continuous subcutaneous insulin infusion Continuous glucose monitoring Diabetes education Closed-loop systems 743 746 4 04/12/22 20220501 NES 220501 Introduction One of the latest automated insulin Delivery (AID) systems is the advanced hybrid closed-loop (AHCL), the MiniMed 780G system (Medtronic, Northridge, CA, USA), which automatically delivers basal insulin with a customizable glucose target in addition to automated bolus correction, as required. Type 1 diabetes, Continuous glucose monitoring, Diabetes education, Closed-loop systems, Continuous subcutaneous insulin infusion. [Extracted from the article]